The document summarizes the pharmaceutical market and healthcare system of Georgia. It describes Georgia's transition to independence in the 1990s which resulted in economic decline and deterioration of health status. However, there have been some recent positive trends, including increased government expenditure on health. The pharmaceutical market in Georgia faces challenges from the country's economic and political environment, as well as health issues like high smoking rates and rising noncommunicable diseases. The report provides an overview of Georgia's pharmaceutical market segments, leading companies, healthcare funding, and forecasts for market growth through 2013.

1. 2010
GEORGIA:in prospect

2. Georgian Pharmaceutical Market
The access to the pharmaceutical marketplace of any region is always paired with risks,
challenges and political, financial and economical factors specific to each region.
Georgia is situated in the central and western parts of the Caucasus. It borders substantially from just over 4 in 1991 to 0.70 in 1998 to 0.5 in 1999. Levels of
Armenia, Azerbaijan, the Russian Federation and Turkey. On 9 April 1991, the financing are below those required to provide basic care to the population and
Supreme Council of Georgia adopted a declaration on the independence of maintain the health care facilities. After the Rose Revolution in 2004,
Georgia. On 31 July 1992, Georgia became the 179th Member of the United Government expenditure on health has been increasing both as a percentage of
Nations. In early 2004, Georgia welcomed major changes in its political situation. GDP (from 1.37 in 2003 to 1.75 in 2005) and as percentage of total health
Mr. Mikhail Saakashvili was elected President of Georgia by popular vote on 4 expenditure (from 26.6 in 2003 to 30.6 in 2005). Total health expenditure is
January 2004. Georgia's main economic activities include: the cultivation of relatively low – 5.8% of GDP, of which a large part is private expenditure.
agricultural products, such as citrus fruits, tea, hazelnuts, and grapes; mining of The leading cause of mortality among the Georgian population is
manganese and copper; and the production of alcoholic and non-alcoholic noncommunicable diseases. There has been a certain increase in the number of
beverages, metals, machinery, and chemicals by a relatively small industrial cardiovascular-related deaths (639.6 per 100 000 population, 2001). Malignancies
sector. take second place among the main causes of death, though rates of mortality
Owing to a significant decline in socioeconomic conditions in the 1990s the from malignancies are lower than in other newly independent states (98.7 per
health status of the population deteriorated seriously. There have, however, 100 000 population). The number of external causes of death has increased as
been some positive trends recently. The main issue of concern continues to be well. Mortality and disability resulting from car accidents is a serious problem
poverty, which is the single most important contributor to ill-health. There has and causes serious economic damage.
been an increase in tobacco consumption and drug use. With regards to The high prevalence of smoking among the adult population, and adolescents in
communicable diseases, the situation was at its worst in the middle of the 1990s particular, represents a great health problem in Georgia. Fifty-three per cent of
(lower immunization coverage, re-emergence of communicable diseases) males and 15% of females in the 10–74 years agegroup were smokers in 1998.
followed by a slow recovery. Tuberculosis (TB), malaria, sexually transmitted This is a 10% increase in both genders compared with 1985. The epidemic of
diseases and HIV/AIDS are still problems for the society. tobacco consumption is directly associated with the increased mortality and
Since becoming independent, Georgia has looked to new models for the health morbidity related to cancer, cardiovascular diseases and respiratory diseases.
sector. The Ministry of Labour, Health and Social Affairs remains the key The numbers of alcohol and illicit drug users have increased dramatically as a
strategic health decision-maker. Much of the decision-making power and consequence of the difficult economic situation, the decline in living conditions,
responsibility for funding at the local level has been allocated to twelve regional general frustration and pessimism.
health departments. The State United Social Insurance Fund and the Ministry of
Finance are the key financial players in the health care system. Decentralization Georgia:in prospect is available at
has been a major component of the health reform process since 1995 and was
reiterated in the 2000–2009 strategic health plan. This has made most health care Euros 155.00
providers financially and managerially autonomous. A plan to privatize To know more about our report or to discuss this topic further
hospitals has been approved and the process is expected to take place in 2007.
please do not hesitate to contact us
Nearly all dental clinics and pharmacies have already been privatized.
Tel/Fax: +38 044 206 17 17/18
Government expenditure on health as a percentage of GDP dropped e-mail: office@smd.net.ua

3. Georgia:in prospect
EECCA: Region Features
Economic Development
Pharmaceutical Market: Executive Summary
Pharmaceutical Market: Main Features
Pharmaceutical Market: Structure
Per capita expenses
Georgia
Country profile
Economy
Healthcare system features
Healthcare system funding
Financial flows within the national health system
Trends in healthcare expenditure, 2003-2007
Structure of total healthcare expenditure 2001-2009
Healthcare System Investment Attractiveness
Georgia: Pharma Market
Main features
Weighted average cost of a pack by segments
ATC 1 share. Total market, USD
ATC 1 share. Total market, Units
ATC 1 share. Rx segment, USD
ATC 1 share. Rx segment, Units
DISCLAIMER ATC 1 share. OTC segment, USD
All information contained in this publication
has been researched and compiled from sources ATC 1 share. OTC segment, Units
believed to be accurate and reliable at the time Leading corporations. Total market, USD
of publishing. However, SMD accepts no
liability whatsoever for any loss or damage
Leading corporations. Total market, Units
resulting from errors, inaccuracies or omissions Leading corporations. Rx segment, USD
affecting any part of the publication. All Leading corporations. Rx segment, Units
information is provided without warranty, and
SMD makes no representation of warranty of Leading corporations. OTC segment, USD
any kind as to the accuracy or completeness of Leading corporations. OTC segment, Units
any information hereto contained.
Georgia: Forecast for 2011-2013
Georgia:in prospect Pharmaceutical market, USD
© 2011 SMD
All information contained in this publication is copyrighted in the name of SMD (Support in Market Development), and as such no part of
this publication may be reproduced, repackaged, redistributed, resold in whole or in any part, or used in any form or by any means
graphic, electronic or mechanical, including photocopying, recording, taping, or by information storage or retrieval, or by any other means,
without the express written consent of the publisher.

4. SMD (Support in Market Development) - is a leading provider of market research,
sales management and forecasting services to the pharmaceutical industry.
Researches of:
· Pharmaceutics establishments' purchase and sale audit
· Hospital establishments' purchase audit
· Second distribution audit Ukraine, 03680
· Import medicine analyses Bojenko str., 86i, Kiev
· Doctor prescription analyses Tel/Fax: +38 044 206 17 17/18
· Ad Hoc research e-mail: office@smd.net.ua
· Analytical services http://www.smd.net.ua
Georgia:in prospect
2010